Format

Send to

Choose Destination
Innate Immun. 2013;19(4):368-77. doi: 10.1177/1753425912462615. Epub 2012 Oct 30.

Evaluation of a LPS-based glycoconjugate vaccine against bovine Escherichia coli mastitis: Formation of LPS Abs in cows after immunization with E. coli core oligosaccharides conjugated to hemocyanine.

Author information

1
Research Center Borstel, Leibniz Center for Medicine and Biosciences, Borstel, Germany.

Abstract

The immune response of cows against the core oligosaccharide of Escherichia coli rough mutants (core types R1-R4, K-12 and J-5) was investigated after immunization with a synthetic glycoconjugate composed of deacylated LPS conjugated to hemocyanine (22 animals). Ab formation was measured by ELISA using LPS or deacylated LPS conjugated to BSA as an Ag. The glycoconjugate immunogens were used to vaccinate cows (36 animals), which were then challenged intramammarily with E. coli O 157 (K1 negative, R1 core type). Compared with control groups no protection was observed, although high titers against the R1 core type were detected in vaccinated animals. Western blots using the immune sera showed that the Ab response was directed against the core region and not against the O-antigen, which may explain the failure of the vaccine.

KEYWORDS:

Immune response; bovine mastitis; endotoxin; lipopolysaccharide; serum Abs; vaccine

PMID:
23112009
DOI:
10.1177/1753425912462615
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center